Corcept Therapeutics (CORT) EBIT Margin Growth (5y) (2017 - 2026)

Corcept Therapeutics (CORT) EBIT Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Corcept Therapeutics 8.35 Bn 8.01 Bn 162.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,480.00
Dec 31, 2025 -3,337.00
Sep 30, 2025 -2,371.00
Jun 30, 2025 -2,610.00
Mar 31, 2025 -3,827.00
Dec 31, 2024 -2,595.00
Sep 30, 2024 -1,497.00
Jun 30, 2024 -1,236.00
Mar 31, 2024 -915.00
Dec 31, 2023 -1,387.00
Sep 30, 2023 -1,042.00
Jun 30, 2023 -798.00
Mar 31, 2023 -2,235.00
Dec 31, 2022 -1,889.00
Sep 30, 2022 -47.00
Jun 30, 2022 -558.00
Mar 31, 2022 1,140.00
Dec 31, 2021 1,607.00
Sep 30, 2021 2,355.00
Jun 30, 2021 2,723.00